Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
IMAX vs CNVS: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
IMAX Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 9–1 Matrix Metrics)
IMAX Overall Winner
6-Pillar Tally: IMAX 5 – 1 CNVS
Matrix Metrics: IMAX 9 – 1 CNVS
As of Nov 20, 2026, Imax Corp (IMAX) is the stronger overall head-to-head candidate over Cineverse Corp. (CNVS) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). IMAX carries a Unified Composite Score of 62.2/100 (BUY) at $46.13 (20.3x Forward P/E, 30.5% operating margin), whereas CNVS carries 35.9/100 (SELL) at $1.73 (38.8x Forward P/E, -12.0% operating margin).
- Growth vs. Quality Trade-Off: IMAX earns the overall head-to-head edge with a stronger Unified Composite Score (62.2/100 BUY vs. CNVS 35.9/100 SELL) and 0.36β · 36% Vol risk profile, whereas CNVS leads top-line expansion (+110.0% YoY revenue growth, 0.46x PEG, and 1 of 6 institutional pillars) for higher-beta growth mandates.
- Technical & Structure Timing Caution: IMAX is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 34.1); meanwhile CNVS trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 46.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Executive Snapshot Side-by-Side Composite Ratings & Technical Regime
Ask Alpha AI About IMAX vs CNVS
IMAX
Head-to-Head Winner
Imax Corp
$46.13
-0.11% 1D
Market Cap
$2.5B
TTM Revenue
$484M
Forward P/E
20.3x
Beta / 30D Vol
0.36β · 36% Vol
Unified Composite Score
62.2
BUY
Tech 76.0
Fund 68.0
Flow 64.0
Mom 60.0
Weinstein Technical Phase
Markdown · Sell / avoid
CNVS
Cineverse Corp. Class A Common Stock
$1.73
-5.46% 1D
Market Cap
$49.1M
TTM Revenue
$99M
Forward P/E
38.8x
Beta / 30D Vol
1.19β · 110% Vol
Unified Composite Score
35.9
SELL
Tech 15.0
Fund 36.0
Flow 54.0
Mom 50.0
Weinstein Technical Phase
Neutral · Hold
6-Pillar Scorecard Institutional Category Breakdown (IMAX 5 – 1 CNVS)
1. Valuation Multiples
IMAX
Forward P/E
20.3x
38.8x
Trailing P/E
19.6x
38.8x
PEG Ratio
1.05x
0.46x
EV / Revenue
5.3x
0.7x
2. Growth & Scale
IMAX
Revenue Growth (YoY)
+63.7%
+110.0%
Earnings Growth (YoY)
+429.7%
+21.1%
TTM Revenue (USD)
$484M
$99M
Market Cap
$2.5B
$49.1M
3. Profitability & Quality
IMAX
Gross Margin
63.6%
42.7%
Operating Margin
30.5%
-12.0%
Net Profit Margin
27.7%
-2.1%
Return on Equity (ROE)
27.6%
-4.6%
4. Balance Sheet & Cash Flow
IMAX
Cash Generation (TTM)
$192M EBITDA
-$18M
Cash Flow Margin
39.7% EBITDA Mgn
-17.9%
Net Cash / Leverage
$36M Net Debt (0.50x D/E)
$22M Net Debt (0.65x D/E)
Dividend Yield
None (0.00%)
None (0.00%)
5. Options & Positioning
IMAX
Options Structure Phase
CONSOLIDATION
UNCLASSIFIED
Current IV / %ile
41.8% (5th %ile)
131.8% (28th %ile)
Put/Call OI Skew
3.04x (Put-Skewed)
N/A
OBV Trend / Tech Phase
DISTRIBUTION · Markdown
NEUTRAL · Neutral
6. R&D & Supply-Chain Moat
CNVS
OpEx & R&D Intensity
33.1% of Rev ($160M)
54.7% of Rev ($54M)
90D R&D Disclosures
0 papers
0 papers
Competitive Moat
High-Margin Pricing Power Moat
Cyclical / Execution-Driven Positioning
Supply-Chain Role
Entertainment Operator
Entertainment Operator
Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table
Core Matrix Wins: IMAX (9) vs CNVS (1)| Institutional Metric | IMAX | CNVS | Criterion | Row Edge |
|---|---|---|---|---|
| Market Capitalization | $2.5B | $49.1M | IMAX | |
| Trailing P/E Ratio | 19.6x | 38.8x | IMAX | |
| Forward P/E Ratio | 20.3x | 38.8x | IMAX | |
| Revenue Growth (YoY) | +63.7% | +110.0% | CNVS | |
| Operating Margin (TTM) | 30.5% | -12.0% | IMAX | |
| Net Profit Margin | 27.7% | -2.1% | IMAX | |
| Return on Equity (ROE) | 27.6% | -4.6% | IMAX | |
| 52-Week Range Position | 54% ($33–$58) | 16% ($1–$3) | IMAX | |
| Beta / 30D Volatility | 0.36β · 36% Vol | 1.19β · 110% Vol | IMAX | |
| Unified Institutional Score | 62.2 / 100 (BUY) | 35.9 / 100 (SELL) | IMAX | |
| Trailing 12M Revenue (USD) | $484M | $99M | Scale | |
| Gross Profit Margin (TTM) | 63.6% | 42.7% | Quality | |
| PEG Ratio & EV / Revenue | 1.05x PEG · 5.3x EV/Rev | 0.46x PEG · 0.7x EV/Rev | Valuation | |
| Cash Flow & Balance Sheet | $192M EBITDA ($36M Net Debt (0.50x D/E)) | -$18M ($22M Net Debt (0.65x D/E)) | Solvency |
Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)
1M Horizon
CNVS +24.15 pp
3M Horizon
IMAX +16.08 pp
6M Horizon
IMAX +47.31 pp
1Y Horizon
IMAX +59.01 pp
Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | IMAX Revenue | CNVS Revenue | IMAX Op. Margin | CNVS Op. Margin | Margin Leader |
|---|---|---|---|---|---|
| FY2019 | $400M | $50M | 19.5% | -10.5% | IMAX |
| FY2020 | $140M | $0M | -88.9% | -310.6% | IMAX |
| FY2021 | $250M | $0M | 4.3% | -2245.5% | IMAX |
| FY2022 | $300M | $60M | -1.6% | -1.7% | IMAX |
| FY2023 | $370M | $70M | 13.4% | -13.1% | IMAX |
| FY2024 | $350M | $50M | 12.5% | -32.0% | IMAX |
| FY2025 | $410M | $80M | 20.5% | 10.1% | IMAX |
| FY2026 | N/A | $70M | N/A | -23.1% | CNVS |
Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor
Live Options Phase Tracker
IMAX
CONSOLIDATION
Current IV
41.8%
IV Percentile
5th %ile
Put/Call OI Skew
3.04x (Put-Skewed)
IV Regime
Compressed (<25th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
BEARISH
OBV Flow
DISTRIBUTION
Exact IMAX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
CNVS
UNCLASSIFIED
Current IV
131.8%
IV Percentile
28th %ile
Put/Call OI Skew
N/A
IV Regime
Balanced (25th–60th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
BEARISH
OBV Flow
NEUTRAL
Exact CNVS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity
Corporate R&D & Foundry Leaderboard
IMAX Moat Profile
High-Margin Pricing Power Moat
Entertainment Operator
OpEx & R&D Reinvestment
33.1% of Rev ($160M)
90D Engineering Disclosures
0 Published
CNVS Moat Profile
Cyclical / Execution-Driven Positioning
Entertainment Operator
OpEx & R&D Reinvestment
54.7% of Rev ($54M)
90D Engineering Disclosures
0 Published
Investor FAQ IMAX vs CNVS Key Questions & Quantitative Answers
As of Nov 20, 2026, Imax Corp (IMAX) is the stronger overall head-to-head candidate over Cineverse Corp. (CNVS) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). IMAX carries a Unified Composite Score of 62.2/100 (BUY) at $46.13 (20.3x Forward P/E, 30.5% operating margin), whereas CNVS carries 35.9/100 (SELL) at $1.73 (38.8x Forward P/E, -12.0% operating margin). Growth vs. Quality Trade-Off: IMAX earns the overall head-to-head edge with a stronger Unified Composite Score (62.2/100 BUY vs. CNVS 35.9/100 SELL) and 0.36β · 36% Vol risk profile, whereas CNVS leads top-line expansion (+110.0% YoY revenue growth, 0.46x PEG, and 1 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: IMAX is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 34.1); meanwhile CNVS trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 46.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
IMAX leads the Growth & Scale pillar: IMAX posts +63.7% YoY revenue growth and +429.7% YoY earnings growth on $484M TTM revenue (63.6% gross margin, 30.5% operating margin), compared with CNVS at +110.0% YoY revenue growth and +21.1% YoY earnings growth on $99M TTM revenue (42.7% gross margin, -12.0% operating margin). Across the 8-period historical trajectory (FY2019 to FY2026), IMAX cumulative revenue shifted +2.5% while CNVS shifted +40.0%. In operating R&D and SG&A reinvestment, IMAX deploys 33.1% of Rev ($160M) (0 90-day corporate R&D disclosures) versus 54.7% of Rev ($54M) (0 disclosures) for CNVS.
IMAX screens cheaper on headline valuation multiples. IMAX trades at 20.3x Forward P/E, 19.6x Trailing P/E, 1.05x PEG, and 5.3x EV/Revenue (39.7% EBITDA margin), whereas CNVS trades at 38.8x Forward P/E, 38.8x Trailing P/E, 0.46x PEG, and 0.7x EV/Revenue (-17.9% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against IMAX (27.6% ROE) versus CNVS (-4.6% ROE) capital efficiency.
In options market volatility and institutional positioning, IMAX carries 41.8% implied volatility (5th %ile, Compressed (<25th %ile)), a 3.04x (Put-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.36β · 36% Vol realized risk). By comparison, CNVS carries 131.8% implied volatility (28th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.19β · 110% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Launch Custom Ticker Comparison →
CNVS vs IMAX · Reverse Pair
IMAX vs CNK
· Sector Peer
IMAX vs LYV
· Sector Peer
IMAX vs PLAY
· Sector Peer
INTC vs AMD
· x86 & Data Center CPU
NVDA vs AMD
· AI Accelerators
TSM vs ASML
· Foundry & Lithography
MSFT vs GOOGL
· Hyperscale Cloud & AI
AAPL vs META
· Consumer Ecosystem
LLY vs NVO
· GLP-1 Biopharma
AVGO vs MRVL
· Custom ASIC & Networking